Last update Feb. 2, 2025
Compatible
We do not have alternatives for Rifaximin since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Rifaximin is also known as
Rifaximin in other languages or writings:
Rifaximin belongs to these groups or families:
Main tradenames from several countries containing Rifaximin in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | < 0.4 | % |
Molecular weight | 786 | daltons |
Protein Binding | 68 | % |
T½ | 2.5 - 6 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by La Liga de la Leche, España of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Rifamycin-derived antibiotic, non-absorbable, used orally to treat certain diarrhoea and intestinal disorders and topically in dermatology.
At the time of the last update, we found no published data on breastfeeding, but its almost complete lack of intestinal absorption (< 1%) and its high molecular weight make it very unlikely to pass into milk. (Chen 2010).
On the other hand, its possible side effects are mild, infrequent and almost limited to abdominal discomfort. (Salix 2023, PDR 2014, Alfa 2011)
Expert authors consider the use of this medication during breastfeeding to be probably compatible. (LactMed, Hale, Briggs 2015, Cheb 2010, Mahadevan 2006).